Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026)

Organogenesis Holdings has reported Other Operating Expenses for 7 years, with the latest figure at $22.5 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 23.46% year-over-year to $22.5 million in Q2 2026; TTM through Jun 2026 was $137.3 million, a 27.81% decrease from a year earlier, with the FY2025 full-year figure at $148.7 million, up 7.33% from the prior year.
• Other Operating Expenses was $22.5 million for Q2 2026 at Organogenesis Holdings, down from $25.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $106.5 million in Q4 2023, with the low at $22.5 million in Q2 2026.
• Average Other Operating Expenses over 4 years is $48.6 million, with a median of $33.7 million recorded in 2025.
• The largest YoY upside for Other Operating Expenses was 38.73% in 2025 against a maximum downside of 50.0% in 2025.
• Over 4 years, Other Operating Expenses stood at $106.5 million in 2023, then declined by 2.59% to $103.7 million in 2024, then tumbled by 50.0% to $51.9 million in 2025, then plunged by 56.64% to $22.5 million in 2026.
• The last three Other Operating Expenses figures came in at $22.5 million (Q2 2026), $25.8 million (Q1 2026), and $51.9 million (Q4 2025), per Business Quant data.